EQS-Adhoc: Marinomed Biotech AG: Publication of a report on the exclusion of subscription rights for a possible second cash capital…
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Corporate Action/Capital
Increase
Marinomed Biotech AG: Publication of a report on the exclusion of
subscription rights for a possible second cash capital in-crease of up to
154,053 shares
27-Nov-2024 / 12:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
Group AG.
The issuer is solely responsible for the content of this announcement.!-->…